Global Statistics

All countries
164,283,858
Confirmed
Updated on May 18, 2021 2:01 am
All countries
144,221,367
Recovered
Updated on May 18, 2021 2:01 am
All countries
3,404,750
Deaths
Updated on May 18, 2021 2:01 am
Tuesday, May 18, 2021

Global Statistics

All countries
164,283,858
Confirmed
Updated on May 18, 2021 2:01 am
All countries
144,221,367
Recovered
Updated on May 18, 2021 2:01 am
All countries
3,404,750
Deaths
Updated on May 18, 2021 2:01 am
Molderizer and Safe Shield

Johnson & Johnson coronavirus vaccine delivers $100M in sales

Coronavirus live updates: Hugs and indoor dining allowed in England as restrictions ease

Over the past week, Taiwan has reported more than 700 local infections and raised its coronavirus alert level twice in the capital, Taipei,...

Gravitas: Is a 'medical cartel' controlling coronavirus supplies in the US?

Are six medical supplies companies profiteering from the Coronavirus outbreak in the US? A program created by US President Donald Trump's son-in-law Jared ... source

FDA authorizes Pfizer and BioNTech's Covid-19 vaccine for emergency use

The US Food and Drug Administration has authorized Pfizer and BioNTech's coronavirus vaccine for emergency use in the United States. CNN's Chris Cuomo ... source

Covid-19 and Vaccine News: Live Updates

Here’s what you need to know:VideotranscriptBacktranscriptBiden Says U.S. Will Be an ‘Arsenal of Vaccines’ for the WorldPresident Biden said on Monday the U.S....

Maine doctors answer COVID-19 vaccine questions

Get the Facts on the Vax: Maine doctors answer your COVID-19 vaccine questions


Johnson & Johnson raked in $100 million in first-quarter sales from its single-shot COVID-19 vaccine that was put on hold last week by the U.S. Food and Drug Administration. 

The New Brunswick, New Jersey-based drugmaker did not provide an update on the state of the vaccine alongside its quarterly results, but is expected to do so later this week. 

“Johnson & Johnson delivered a strong first quarter performance led by the above market growth of our Pharmaceutical business and continued recovery in Medical Devices,” CEO Alex Gorsky said in a statement. 

Net earnings in the three months through March rose 6.9% year over year to $6.2 billion, or an adjusted $2.59 per diluted share. Revenue was $22.32 billion.

Wall Street analysts surveyed by Refinitiv were expecting adjusted earnings of $2.34 per share on revenue of $21.98 billion.

Looking ahead, Johnson & Johnson tweaked its full-year adjusted profit forecast to between $9.42 and $9.57 per share versus its prior forecast of $9.40 to $9.60 per share. 

This story is developing. Check back for updates. 



Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Popular

Coronavirus live updates: Hugs and indoor dining allowed in England as restrictions ease

Over the past week, Taiwan has reported more than 700 local infections and raised its coronavirus alert level twice in the capital, Taipei,...

Gravitas: Is a 'medical cartel' controlling coronavirus supplies in the US?

Are six medical supplies companies profiteering from the Coronavirus outbreak in the US? A program created by US President Donald Trump's son-in-law Jared ... source

FDA authorizes Pfizer and BioNTech's Covid-19 vaccine for emergency use

The US Food and Drug Administration has authorized Pfizer and BioNTech's coronavirus vaccine for emergency use in the United States. CNN's Chris Cuomo ... source

Related Articles

Coronavirus live updates: Hugs and indoor dining allowed in England as restrictions ease

Over the past week, Taiwan has reported more than 700 local infections and raised its coronavirus alert level twice in the capital, Taipei,...

Gravitas: Is a 'medical cartel' controlling coronavirus supplies in the US?

Are six medical supplies companies profiteering from the Coronavirus outbreak in the US? A program created by US President Donald Trump's son-in-law Jared ... source

FDA authorizes Pfizer and BioNTech's Covid-19 vaccine for emergency use

The US Food and Drug Administration has authorized Pfizer and BioNTech's coronavirus vaccine for emergency use in the United States. CNN's Chris Cuomo ... source